• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Exact Sciences Corporation - Common Stock (NQ: EXAS )

    57.48 -0.63 (-1.08%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 951,135
    Open 57.86
    Bid (Size) 57.48 (11)
    Ask (Size) 58.50 (1)
    Prev. Close 58.11
    Today's Range 57.29 - 58.66
    52wk Range 40.62 - 79.62
    Shares Outstanding 171,948,769
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Rivian Automotive, Rocket Lab And Moderna Are Among Top 10 Large-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
    Top performers last week: RIVN, RKLB, SRPT, EXAS, ESTC, ULTA, MRNA, RL, CPRT, SNAP. Any in your portfolio? Citigroup raises price target on ULTA and SNAP. 
    Via Benzinga
    What 19 Analyst Ratings Have To Say About Exact Sciences
    Via Benzinga

    Performance

    YTD
    -22.08%
    -22.08%
    1 Month
    -4.36%
    -4.36%
    3 Month
    -15.40%
    -15.40%
    6 Month
    +29.20%
    +29.20%
    1 Year
    -24.05%
    -24.05%

    More News

    Read More
    Why Is Exact Sciences Stock Trading Higher On Monday?
    Via Benzinga
    J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Will EXACT SCIENCES CORP breakout?
    Via Chartmill
    Deep Dive Into Exact Sciences Stock: Analyst Perspectives (7 Ratings)
    Via Benzinga
    (EXAS) - Analyzing Exact Sciences's Short Interest
    Via Benzinga
    US Stocks May Have A Slow Start As Trump's Tariff Threat Begins To Thwart Relief Rally: Analysts Remain Optimistic About AI-Linked Sectors Stocks
    Via Benzinga
    Topics Government
    Exposures Political
    Exact Sciences to Participate in December Investor Conferences
    From Exact Sciences Corp.
    Via Business Wire
    Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024
    From Exact Sciences Corp.
    Via Business Wire
    Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy
    From Exact Sciences Corp.
    Via Business Wire
    Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken?
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point
    Via Benzinga
    Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Tesla Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Exact Sciences Stock Plummets After Worse-Than-Expected Q3 Results, FY24 Guidance Below Estimates
    Via Benzinga
    Exact Sciences Announces Third-Quarter 2024 Results
    From Exact Sciences Corp.
    Via Business Wire
    Exact Sciences to Participate in November Investor Conference
    From Exact Sciences Corp.
    Via Business Wire
    Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement
    From Exact Sciences Corp.
    Via Business Wire
    Can This Beaten-Down Cathie Wood Stock Bounce Back?
    Via The Motley Fool
    Exact Sciences Schedules Third Quarter 2024 Earnings Call
    From Exact Sciences Corp.
    Via Business Wire
    FDA Clears Exact Sciences' Next-Generation Colorectal Cancer Diagnostic Test
    Via Benzinga
    Exposures Product Safety
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.